Moving the goal posts in prostate cancer trials
Lancet Oncol
.
2015 Mar;16(3):247-9.
doi: 10.1016/S1470-2045(15)70071-9.
Epub 2015 Feb 18.
Authors
Ravi A Madan
1
,
James L Gulley
2
Affiliations
1
National Cancer Institute, National Institutes of Health, Center Drive, Bethesda, MD 20892, USA.
2
National Cancer Institute, National Institutes of Health, Center Drive, Bethesda, MD 20892, USA. Electronic address:
[email protected]
.
PMID:
25701172
PMCID:
PMC6632068
DOI:
10.1016/S1470-2045(15)70071-9
No abstract available
Publication types
Comment
MeSH terms
Adenocarcinoma / drug therapy*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Male
Prostatic Neoplasms, Castration-Resistant / drug therapy*
Grants and funding
Z01 BC010945-01/Intramural NIH HHS/United States